Verified peer comparison
Humacyte vs Dianthus Therapeutics Financial Comparison
Direct answer
Humacyte and Dianthus Therapeutics are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free Humacyte email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Humacyte Revenue
- 2,038,000 USD
- Dianthus Therapeutics Revenue
- 2,036,000 USD
- Humacyte Operating income
- -107,437,000 USD
- Dianthus Therapeutics Operating income
- -177,933,000 USD